浙江医药
(600216)
| 流通市值：160.88亿 | | | 总市值：160.88亿 |
| 流通股本：9.62亿 | | | 总股本：9.62亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,635,716,620.56 | 1,468,842,479.23 | 1,584,294,142.41 | 1,460,026,640.19 |
| 应收票据及应收账款 | 1,690,337,783.45 | 1,395,634,148.29 | 1,481,522,600.11 | 1,252,230,303.53 |
| 应收账款 | 1,690,337,783.45 | 1,395,634,148.29 | 1,481,522,600.11 | 1,252,230,303.53 |
| 应收款项融资 | 214,570,975.78 | 258,418,548.86 | 214,211,932.2 | 167,121,689.07 |
| 预付款项 | 122,750,233.14 | 120,818,624.79 | 112,625,939.82 | 94,031,721.04 |
| 其他应收款合计 | 134,880,569.14 | 97,759,927.31 | 97,332,548.05 | 239,136,451.64 |
| 存货 | 1,945,483,588.92 | 1,907,058,263.75 | 1,813,789,960.07 | 2,010,704,310.63 |
| 其他流动资产 | 74,762,702.54 | 65,491,411.92 | 75,294,179.24 | 49,848,344.42 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 6,146,702,104.36 | 5,669,917,652.8 | 5,666,395,143.63 | 5,601,409,763.89 |
| 非流动资产: | | | | |
| 长期股权投资 | 77,135,930.71 | 78,766,319.95 | 87,385,542.42 | 88,230,562.69 |
| 其他非流动金融资产 | 73,457,421.71 | 75,313,059.21 | 76,713,886.82 | 77,981,663.25 |
| 投资性房地产 | 92,602,361.5 | 93,301,276.9 | 94,000,192.3 | 94,699,107.7 |
| 固定资产 | 4,965,911,138.13 | 4,859,572,739.77 | 4,926,143,883.16 | 5,064,304,310.62 |
| 在建工程 | 1,193,715,133.97 | 1,211,242,597.43 | 1,122,031,169.06 | 931,694,664.92 |
| 使用权资产 | 23,429,029.82 | 23,048,873.01 | 23,246,594.76 | 23,444,316.51 |
| 无形资产 | 698,669,085.79 | 709,420,707.29 | 728,666,758.81 | 744,304,016.85 |
| 商誉 | 18,680,361.98 | 18,680,361.98 | 18,680,361.98 | 18,680,361.98 |
| 长期待摊费用 | 12,441,031.93 | 4,920,163.5 | 5,573,863.56 | 6,215,857.62 |
| 递延所得税资产 | 84,475,322.15 | 78,988,211.47 | 89,071,340.49 | 82,121,878.92 |
| 其他非流动资产 | 42,293,191.26 | 54,707,324.96 | 71,859,273.33 | 46,453,251.26 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,282,810,008.95 | 7,207,961,635.47 | 7,243,372,866.69 | 7,178,129,992.32 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 13,429,512,113.31 | 12,877,879,288.27 | 12,909,768,010.32 | 12,779,539,756.21 |
| 流动负债: | | | | |
| 短期借款 | 235,226,300 | 235,226,300 | 235,258,900 | 200,223,000 |
| 应付票据及应付账款 | 1,173,478,371.54 | 1,116,600,491.58 | 1,149,272,424 | 1,150,150,148.12 |
| 其中：应付票据 | 29,010,297.6 | 27,932,262.17 | 46,159,223.97 | 20,328,976.51 |
| 应付账款 | 1,144,468,073.94 | 1,088,668,229.41 | 1,103,113,200.03 | 1,129,821,171.61 |
| 合同负债 | 45,685,386.54 | 43,465,220.07 | 53,709,801.66 | 43,952,226.63 |
| 应付职工薪酬 | 137,629,829.37 | 100,631,093.94 | 86,818,951.14 | 174,615,446.6 |
| 应交税费 | 211,927,001.35 | 73,373,270.39 | 79,194,236.83 | 91,716,456.18 |
| 其他应付款合计 | 408,797,933.37 | 414,880,752.35 | 537,131,406.7 | 442,661,673.25 |
| 应付股利 | 29,971.18 | 2,014,859 | 29,971.18 | 29,971.18 |
| 一年内到期的非流动负债 | 141,662,765.84 | 141,450,793.58 | 239,545,290.55 | 370,674,923.25 |
| 其他流动负债 | 3,737,452.76 | 4,192,258.31 | 4,221,060.6 | 4,448,416.19 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,358,145,040.77 | 2,129,820,180.22 | 2,385,152,071.48 | 2,478,442,290.22 |
| 非流动负债: | | | | |
| 长期借款 | 372,307,500 | 424,357,700 | 376,355,500 | 230,222,800 |
| 租赁负债 | 534,489.41 | 162,328.39 | 335,747.71 | 322,843.87 |
| 递延收益 | 89,123,759.93 | 78,782,534.68 | 81,470,293.11 | 84,158,052.23 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 461,965,749.34 | 503,302,563.07 | 458,161,540.82 | 314,703,696.1 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,820,110,790.11 | 2,633,122,743.29 | 2,843,313,612.3 | 2,793,145,986.32 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 961,637,750 | 961,637,750 | 964,975,000 | 964,975,000 |
| 资本公积 | 1,987,669,645.8 | 1,986,020,084.21 | 2,007,671,468.83 | 2,005,399,439.76 |
| 减:库存股 | - | - | 27,632,430 | 27,632,430 |
| 其他综合收益 | 4,383,624.88 | 1,781,332.61 | 2,062,456.65 | 5,769,416.91 |
| 盈余公积 | 1,647,513,860.84 | 1,647,513,860.84 | 1,647,513,860.84 | 1,647,513,860.84 |
| 未分配利润 | 5,740,096,409.49 | 5,350,022,271.85 | 5,144,339,892.29 | 5,034,690,253.98 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 10,341,301,291.01 | 9,946,975,299.51 | 9,738,930,248.61 | 9,630,715,541.49 |
| 少数股东权益 | 268,100,032.19 | 297,781,245.47 | 327,524,149.41 | 355,678,228.4 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 10,609,401,323.2 | 10,244,756,544.98 | 10,066,454,398.02 | 9,986,393,769.89 |
| 负债和股东权益合计 | 13,429,512,113.31 | 12,877,879,288.27 | 12,909,768,010.32 | 12,779,539,756.21 |
| 公告日期 | 2024-10-25 | 2024-08-23 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |